Episode 59 - UV Exposure for Skin Conditions a session from SF Derm Society 2024 Annual Meeting | The Future of Dermatology Podcast
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Summary
Dr. Mehdi Rashighi, MD, discusses groundbreaking research in dermatology focusing on autoimmune skin diseases. The conversation delves into multiomics research, the role of interferons in skin diseases, and the impact of UV exposure on conditions like cutaneous lupus and dermatomyositis. The episode highlights the importance of understanding cytokine signatures and the potential for new treatments targeting specific immune cells.
Takeaways
- The SFDerm 2024 meeting showcased significant advancements in dermatology.
- Multiomics research is crucial for understanding autoimmune skin diseases.
- Type one interferon plays a key role in cutaneous lupus and dermatomyositis.
- Cytokine signatures can help identify new treatment targets.
- Plasmacytoid dendritic cells are important in the pathogenesis of lupus.
- UV exposure can exacerbate skin diseases like lupus and dermatomyositis.
- Clinical trials are exploring monoclonal antibodies against interferons.
- Understanding photosensitivity is vital for managing lupus patients.
- Research is ongoing to better understand the immune response in skin diseases.
Chapters
00:00 - Introduction to the Future of Dermatology Podcast
00:56 - Exploring Multiomics in Dermatology Research
02:53 - Understanding Interferon Signatures in Skin Diseases
05:58 - Photosensitivity in Cutaneous Lupus and Dermatomyositis